炎症性肠病患者结直肠癌诊断机会错失的根本原因分析
本研究对炎症性肠病相关结直肠癌患者进行根本原因分析,并与一般人群结直肠癌患者匹配比较。结果显示炎症性肠病患者发生结直肠癌风险增加(比值比2.7,95%CI 1.6-3.9,P<0.001),1998至2019年间发病率无变化;符合监测条件的患者中三分之二存在诊断机会错失。匹配病例对照分析未显示癌症分期或10年生存结局的显著差异。
要点
- 炎症性肠病患者结直肠癌风险增加,比值比2.7(95%CI 1.6-3.9,P<0.001)。
- 符合监测条件的患者中,64%(27/42)存在结肠镜监测机会错失。
- 匹配病例对照分析未显示癌症分期或10年生存的显著差异。
核心结论
- 炎症性肠病相关结直肠癌发病率保持稳定,三分之二符合结肠镜监测条件的患者存在诊断机会错失。
- 缺乏初级和二级医疗全面整合召回系统的监测方案注定失败。
研究设计与样本
- 在本院开展根本原因分析,识别炎症性肠病相关结直肠癌诊断机会错失的患者。
- 将炎症性肠病相关结直肠癌患者与一般人群结直肠癌患者进行匹配,比较诊断时分期和临床结局。
- 共78例患者发生炎症性肠病相关结直肠癌。
主要发现
- 与一般人群相比,炎症性肠病患者发生结直肠癌风险增加(比值比2.7,95%CI 1.6-3.9,P<0.001)。
- 1998至2019年间炎症性肠病相关结直肠癌平均发病率为每10万患者165.4(IQR 130.4-199.4),过去20年无变化。
- 42例(54%)患者符合结直肠癌监测条件:12%(5/42)在适时监测结肠镜检查时诊断结直肠癌,10%(4/42)在逾期监测结肠镜检查时诊断。
- 14%(6/42)患者发生间期癌;64%(27/42)患者存在结肠镜监测机会错失,根本原因分析显示10/27(37%)已知在二级医疗的患者未获监测建议。
- 4例(15%)患者因未考虑既往结肠镜检查发现而延迟诊断结直肠癌;17例(63%)患者由初级医疗管理,包括7例从二级医疗出院时无监测计划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colonoscopic surveillance in patients with inflammatory bowel disease (IBD) leads to earlier detection of colorectal cancer (CRC) and reduces CRC-associated mortality. However, it is limited by poor adherence in practice. AIM: To identify missed opportunities to detect IBD-associated CRC at our hospital METHODS: We undertook root-cause analyses to identify patients with missed opportunities to diagnose IBD-associated CRC. We matched patients with IBD-associated CRC to patients with CRC in the general population to identify differences in staging at diagnosis and clinical outcomes. RESULTS: Compared with the general population, patients with IBD were at increased risk of developing CRC (odds ratio 2.7 [95% CI 1.6-3.9], P < 0.001). The mean incidence of IBD-associated CRC between 1998 and 2019 was 165.4 (IQR 130.4-199.4) per 100 000 patients and has not changed over the last 20 years. Seventy-eight patients had IBD-associated CRC. Forty-two (54%) patients were eligible for CRC surveillance: 12% (5/42) and 10% (4/42) patients were diagnosed with CRC at an appropriately timed or overdue surveillance colonoscopy, respectively. Interval cancers occurred in 14% (6/42) of patients; 64% (27/42) of patients had a missed opportunity for colonoscopic surveillance where root-cause analyses demonstrated that 10/27 (37%) patients known to secondary care had not been offered surveillance. Four (15%) patients had a delayed diagnosis of CRC due to failure to account for previous colonoscopic findings. Seventeen (63%) patients were managed by primary care including seven patients discharged from secondary care without a surveillance plan. Matched case-control analysis did not show significant differences in cancer staging or 10-year survival outcomes. CONCLUSION: The incidence of IBD-associated CRC has remained static. Two-thirds of patients eligible for colonoscopic surveillance had missed opportunities to diagnose CRC. Surveillance programmes without comprehensive and fully integrated recall systems across primary and secondary care are set to fail.
引用
- Gordon C, Chee D, Hamilton B, et al. Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020. PMID: 33159472. doi:10.1111/apt.16155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。